Optimizing Treatment Approaches and Evolution of HER2 Targeting in mCRC

Evolution of HER2 as an Actionable Target Across Solid Tumors

Saturday, July 2, 2022

13:40 – 13:55

Location: Rooms 115-116; Level 1

Session Speaker(s)

Andrea Cercek, MD

Memorial Sloan Kettering Cancer Center
New York, United States

Supported by Seagen